Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M Lewis

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Biochemical and Biophysical Research Communications|September 22, 2012
β-Adrenergic receptor signaling increases NAADP and cADPR levels in the heartAlexander M Lewis, Parvinder K Aley, Ali Roomi, et al.
Nature Genetics|March 12, 2026
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesisIrenaeus C C Chan, Pu Zhang, Xiangyu Pan, et al.
Molecular Cell|April 30, 2024
GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignanciesSalima Benbarche, Jose Mario Bello Pineda, Laura Baquero Galvis, et al.
The Journal of Biological Chemistry|July 9, 2015
Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Endolysosomal Two-pore Channels Modulate Membrane Excitability and Stimulus-Secretion Coupling in Mouse Pancreatic β CellsAbdelilah Arredouani, Margarida Ruas, Stephan C Collins, et al.
Blood|August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid LeukemiaMark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Cell|April 24, 2025
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemiasWon Jun Kim, Edie I Crosse, Emma De Neef, et al.
Cancer Discovery|April 30, 2026
Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute LeukemiasTakeshi Fujino, Jennifer Lewis, Bingyi Chen, et al.
Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biochemical and Biophysical Research Communications|September 22, 2012
β-Adrenergic receptor signaling increases NAADP and cADPR levels in the heartAlexander M Lewis, Parvinder K Aley, Ali Roomi, et al.
Nature Genetics|March 12, 2026
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesisIrenaeus C C Chan, Pu Zhang, Xiangyu Pan, et al.
Molecular Cell|April 30, 2024
GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignanciesSalima Benbarche, Jose Mario Bello Pineda, Laura Baquero Galvis, et al.
The Journal of Biological Chemistry|July 9, 2015
Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Endolysosomal Two-pore Channels Modulate Membrane Excitability and Stimulus-Secretion Coupling in Mouse Pancreatic β CellsAbdelilah Arredouani, Margarida Ruas, Stephan C Collins, et al.
Blood|August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid LeukemiaMark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Cell|April 24, 2025
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemiasWon Jun Kim, Edie I Crosse, Emma De Neef, et al.
Cancer Discovery|April 30, 2026
Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute LeukemiasTakeshi Fujino, Jennifer Lewis, Bingyi Chen, et al.
Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Pageof 3